Evidence map›Paper›PMID 39618727›Full record

ArticlePalliative care and social practice2024

Financial cost of end-of-life cancer care in palliative care units (PCUs) and non-PCUs in Iran: insights from low- and middle-income countries.

Ali Darrudi, Amir Hossein Poupak, Rajabali Darroudi, Nasrin Sargazi, Kazem Zendehdel, Libby Sallnow, Ali Ghanbari Motlagh, Mamak Tahmasebi, Azin Nahvijou

Abstract read
In one paragraph

Article in Palliative care and social practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ali DarrudiDepartment of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Amir Hossein PoupakCancer Research center of Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Rajabali DarroudiDepartment of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Nasrin SargaziDepartment of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Kazem ZendehdelCancer Research Center of Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Libby SallnowSt Christopher's Hospice, London, UK.
Ali Ghanbari MotlaghDepartment of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti Medical University, Tehran, Iran.
Mamak TahmasebiCancer Research Center of Cancer Institute, Tehran University of Medical Sciences, End of Keshavarz Boulevard, Tehran 1416753955, Iran.
Azin NahvijouCancer Research Center of Cancer Institute, Tehran University of Medical Sciences, End of Keshavarz Boulevard, Tehran 1416753955, Iran.ORCID https://orcid.org/0000-0003-1973-7638

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: End-of-life care for patients with advanced cancer can impose a significant financial burden. However, data on the economic impact of end-of-life care in low- and middle-income countries are limited. Objective: This study aims to compare the costs associated with palliative care units (PCUs) and non-PCU settings for cancer patients in Iran. Design: We designed a retrospective study at the largest hospital in the country. Methods: We conducted a comprehensive evaluation of hospitalization costs and care service delivery for 150 patients in the final 5 days of life, who were admitted to the largest hospital complex in Iran. All costs were adjusted based on the 2018 USD exchange rate. Results: Among the 150 patients included in the study, 56 (37%) were admitted to the PCU. The average total treatment cost during the final 5 days of life was three times higher in general wards compared to PCUs. In non-PCU settings, the total cost of care during this period amounted to $2873, while in PCU settings, it was $909.63. Conclusion: The establishment of PCUs within tertiary hospitals and the provision of palliative consultation services to patients with advanced cancer can yield significant benefits, even when resources are limited.

Indexed as

cancerend-of-life-care and costIranpalliative care

Identifiers

PMID39618727
PMCPMC11605751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.